Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.410
-0.170 (-10.76%)
At close: May 14, 2025, 4:00 PM
1.240
-0.170 (-12.06%)
After-hours: May 14, 2025, 7:09 PM EDT
Apyx Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Apyx Medical.
Price Target: $0.00 (0.00%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Apyx Medical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +254.61% | Nov 10, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +219.15% | Aug 11, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +467.38% | Jul 14, 2023 |
Financial Forecast
Revenue This Year
48.99M
from 48.10M
Increased by 1.85%
Revenue Next Year
52.77M
from 48.99M
Increased by 7.72%
EPS This Year
-0.42
from -0.66
EPS Next Year
-0.41
from -0.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 50.6M | 54.9M | 63.2M | ||
| Avg | 49.0M | 52.8M | 59.4M | ||
| Low | 46.9M | 50.0M | 55.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.2% | 12.1% | 19.7% | ||
| Avg | 1.8% | 7.7% | 12.5% | ||
| Low | -2.4% | 2.0% | 4.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.40 | -0.39 | -0.38 |
| Avg | -0.42 | -0.41 | -0.37 |
| Low | -0.45 | -0.43 | -0.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.